EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prevalence of Sarcopenia and Dynapenia and Related Clinical Outcomes in Patients with Type 1 Diabetes Mellitus

María Carmen Andreo-López iD, María Teresa Zarco-Martín iD, Victoria Contreras-Bolívar, María Luisa Fernández-Soto

Nutrients · 24.11.2023 · 15 (23) · 4914

DOI: 10.3390/nu15234914 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, online erschienen am 24.11.2023. Verfasst von María Carmen Andreo-López und 3 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology and Nutrition Unit, University Hospital Clínico San Cecilio, 18016 Granada, Spain. Hauptthemen laut MEDLINE: Sarcopenia, Diabetes Mellitus, Type 1. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Investigación Biosanitaria de Granada (Ibs. Granada), Junta de Andalucia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Sarcopenia has recently been recognized as a complication of diabetes. However, there are few results about the prevalence of sarcopenia and dynapenia and the related clinical outcomes in type 1 diabetes mellitus (T1DM). Our objectives were to evaluate the prevalence of sarcopenia and dynapenia and to determine whether there are any associations with disease-related factors in people with T1DM.

Methods

A cross-sectional study was conducted in people with T1DM. We assessed appendicular skeletal mass index (ASMI) using bioimpedance 50 Hz (Nutrilab Akern). Muscle function was assessed through handgrip strength (HGS) using a Jamar dynamometer. Sarcopenia was defined as a low HGS with low ASMI, whereas dynapenia was defined as low HGS with a normal ASMI. We used HGS data from the Spanish population percentile table and a cut-off point at p5 as dynapenia. The association of clinical, metabolic, and lifestyle variables with sarcopenia and dynapenia was studied.

Results

This study included 62 T1DM patients (66% females, mean age of 38 ± 14 years, body mass index (BMI) of 24.9 ± 4.7 kg/m2). The prevalence of sarcopenia and dynapenia was 8% and 23%, respectively. In our sample, there were more men in the sarcopenic and dynapenic groups. The sarcopenic group showed a significantly higher mean HbA1c value. Lower diabetes duration, PREDIMED score, BMI, and muscle mass measures (fat-free mass index (FFMI), ASMI, and body cell mass index (BCMI)) were significantly associated with sarcopenia. Decreased diabetes duration, PREDIMED score, phase angle (PhA), and HGS values showed a significant association with dynapenia.

Conclusions

The prevalence of sarcopenia and dynapenia was high in people with T1DM in our study. Specifically, the proportion of dynapenia was quite high. HGS and ASMI are practical tools for the assessment of muscle health status in T1DM, and low values are associated with poor glycemic control, underweight, and low adherence to the Mediterranean diet. Thus, dynapenia may predict accelerated muscle aging in T1DM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcopeniaDiabetes Mellitus, Type 1MaleFemaleHumansYoung AdultAdultMiddle AgedHand StrengthPrevalenceCross-Sectional StudiesMuscle StrengthMuscle, Skeletal

Stichwörter der Autor:innen

dynapeniasarcopeniatype 1 diabetes mellitus

Autor:innen und Institutionen

  • Endocrinology and Nutrition Unit, University Hospital Clínico San Cecilio, 18016 Granada, Spain.
  • Instituto de Investigación Biosanitaria de Granada (Ibs. Granada), 18012 Granada, Spain.
  • CIBER on Frailty and Healthy Aging (CIBERFES), Instituto de Salud Carlos III, 18012 Granada, Spain.
  • Department of Medicine, University of Granada, 18016 Granada, Spain.

ORCID-Profile: María Carmen Andreo-López, María Teresa Zarco-Martín

Förderung

  • Instituto de Investigación Biosanitaria de Granada (Ibs. Granada)
  • Junta de Andalucia

Zitieren

APA

Andreo-López, M. C., Zarco-Martín, M. T., Contreras-Bolívar, V., & Fernández-Soto, M. L. (2023). Prevalence of Sarcopenia and Dynapenia and Related Clinical Outcomes in Patients with Type 1 Diabetes Mellitus. Nutrients, 15(23), 4914. https://doi.org/10.3390/nu15234914

Vancouver

Andreo-López MC, Zarco-Martín MT, Contreras-Bolívar V, Fernández-Soto ML. Prevalence of Sarcopenia and Dynapenia and Related Clinical Outcomes in Patients with Type 1 Diabetes Mellitus. Nutrients. 2023;15(23):4914. doi:10.3390/nu15234914

BibTeX
@article{AndreoLpez2023,
  author = {Andreo-López, María Carmen and Zarco-Martín, María Teresa and Contreras-Bolívar, Victoria and Fernández-Soto, María Luisa},
  title = {Prevalence of Sarcopenia and Dynapenia and Related Clinical Outcomes in Patients with Type 1 Diabetes Mellitus},
  journal = {Nutrients},
  year = {2023},
  volume = {15},
  number = {23},
  pages = {4914},
  doi = {10.3390/nu15234914}
}
Kostenlos starten →